• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,3,4,5-四氢苯并[d]氮杂䓬-2-酮的区域选择性烷基化及其所得烷基化产物作为潜在选择性5-HT₂c激动剂的生物学评价。

Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective 5-HT₂c agonists.

作者信息

Prajapati Navnit, Giridhar Rajani, Sinha Anshuman, Kanhed Ashish M, Yadav Mange Ram

机构信息

Faculty of Technology & Engineering, Kalabhavan, The M. S. University of Baroda, Vadodara, 390001, Gujarat, India.

出版信息

Mol Divers. 2015 Nov;19(4):653-67. doi: 10.1007/s11030-015-9600-8. Epub 2015 Apr 28.

DOI:10.1007/s11030-015-9600-8
PMID:25916735
Abstract

The benzazepine ring system has offered interesting CNS-active medicinal agents. Taking this privileged structure as the basic scaffold, [Formula: see text] and/or [Formula: see text]-alkylated benzazepin-2-one derivatives and their reduced analogs have been prepared as potential [Formula: see text] receptor agonists. The selective alkylation at the [Formula: see text] and/or [Formula: see text] positions of this seven-membered lactam ring is here reported for the first time under different reaction conditions. The synthesized compounds were evaluated for their biological profile as potential [Formula: see text] agonists using a classic pharmacological approach. Three derivatives (15, 17, and 20) have shown promising [Formula: see text] agonistic activity which can be further optimized as anti-obesity agents for the treatment of male sexual dysfunction. Further, a homology model for [Formula: see text] receptor was generated using MODELLER, and ligand-receptor interactions for these potential molecules were studied.

摘要

苯并氮杂䓬环系统提供了有趣的中枢神经系统活性药物。以这种优势结构作为基本骨架,已制备出[化学式:见原文]和/或[化学式:见原文]-烷基化苯并氮杂䓬-2-酮衍生物及其还原类似物作为潜在的[化学式:见原文]受体激动剂。本文首次报道了在不同反应条件下,对这个七元内酰胺环的[化学式:见原文]和/或[化学式:见原文]位进行选择性烷基化。使用经典药理学方法评估了合成化合物作为潜在[化学式:见原文]激动剂的生物学特性。三种衍生物(15、17和20)显示出有前景的[化学式:见原文]激动活性,可作为治疗男性性功能障碍的抗肥胖药物进一步优化。此外,使用MODELLER生成了[化学式:见原文]受体的同源模型,并研究了这些潜在分子与配体-受体的相互作用。

相似文献

1
Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective 5-HT₂c agonists.1,3,4,5-四氢苯并[d]氮杂䓬-2-酮的区域选择性烷基化及其所得烷基化产物作为潜在选择性5-HT₂c激动剂的生物学评价。
Mol Divers. 2015 Nov;19(4):653-67. doi: 10.1007/s11030-015-9600-8. Epub 2015 Apr 28.
2
Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.一系列作为5-羟色胺2C受体激动剂的苯并氮杂卓衍生物的合成及构效关系
Bioorg Med Chem. 2008 Mar 15;16(6):3309-20. doi: 10.1016/j.bmc.2007.12.009. Epub 2007 Dec 8.
3
Concise synthesis of 2-benzazepine derivatives and their biological activity.2-苯氮杂䓬衍生物的简明合成及生物活性。
J Org Chem. 2012 Apr 20;77(8):4017-28. doi: 10.1021/jo300380z. Epub 2012 Apr 10.
4
Beneficial Effects of Scutellaria baicalensis on Penile Erection in Streptozotocin-Induced Diabetic Rats.黄芩对链脲佐菌素诱导的糖尿病大鼠阴茎勃起的有益作用。
Am J Chin Med. 2016;44(2):305-20. doi: 10.1142/S0192415X1650018X.
5
Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity.新型苯并氮杂卓类化合物作为强效和选择性5-HT(2C)受体激动剂用于治疗肥胖症的发现及构效关系研究
Bioorg Med Chem Lett. 2005 Mar 1;15(5):1467-70. doi: 10.1016/j.bmcl.2004.12.080.
6
Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.通过分子模拟研究发现具有强效降压作用的取代咪唑基联苯磺酰脲类血管紧张素 II AT1 受体拮抗剂配体。
Interdiscip Sci. 2015 Sep;7(3):221-32. doi: 10.1007/s12539-015-0006-1. Epub 2015 Jul 19.
7
Synthesis of 5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-ones: selective antagonists of muscarinic (M3) receptors.5-羟基-2,3,4,5-四氢-[1H]-2-苯并氮杂卓-4-酮的合成:毒蕈碱(M3)受体的选择性拮抗剂
Org Biomol Chem. 2008 Jun 21;6(12):2138-57. doi: 10.1039/b801206g. Epub 2008 Apr 18.
8
Exploring structural requirements for peripherally acting 1,5-diaryl pyrazole-containing cannabinoid 1 receptor antagonists for the treatment of obesity.探索用于治疗肥胖症的外周作用含1,5-二芳基吡唑的大麻素1受体拮抗剂的结构要求。
Mol Divers. 2015 Nov;19(4):871-93. doi: 10.1007/s11030-015-9611-5. Epub 2015 Jul 17.
9
(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.(±)-3-[4'-(N,N-二甲基氨基)肉桂基]苯并氮杂卓类似物:新型多巴胺D1受体拮抗剂。
J Med Chem. 1996 Aug 16;39(17):3423-8. doi: 10.1021/jm960143p.
10
Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.新型精氨酸加压素V(2)受体激动剂(4,4 -二氟-1,2,3,4 -四氢-5H-1 -苯并氮杂卓-5 -亚基)乙酰胺衍生物的制备
Bioorg Med Chem. 2008 Nov 1;16(21):9524-35. doi: 10.1016/j.bmc.2008.09.039. Epub 2008 Sep 17.

本文引用的文献

1
Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.特权结构:高效的化学“导航者”,通向未探索的具有生物学相关性的化学空间。
J Am Chem Soc. 2014 Oct 22;136(42):14629-38. doi: 10.1021/ja508343a. Epub 2014 Oct 13.
2
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.从肥胖到药物滥用:5-HT2C 受体激动剂的治疗机会。
Trends Pharmacol Sci. 2013 Oct;34(10):560-70. doi: 10.1016/j.tips.2013.08.001. Epub 2013 Sep 13.
3
Lorcaserin: a review of its use in chronic weight management.
盐酸氯卡色林:用于慢性体重管理的综述。
Drugs. 2013 Apr;73(5):463-73. doi: 10.1007/s40265-013-0035-1.
4
Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding.α(1) -受体阻滞剂效能的启示——血管紧张素 II 受体的平行阻断:一项新发现。
Pharm Biol. 2012 Apr;50(4):439-42. doi: 10.3109/13880209.2011.611144. Epub 2011 Dec 2.
5
The use of serotonergic drugs to treat obesity--is there any hope?使用血清素能药物治疗肥胖症——有希望吗?
Drug Des Devel Ther. 2011 Feb 10;5:95-109. doi: 10.2147/DDDT.S11859.
6
Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa.西番莲(巴拉圭茶)的抗焦虑和镇静活性。
J Ethnopharmacol. 2010 Mar 2;128(1):148-53. doi: 10.1016/j.jep.2009.12.043. Epub 2010 Jan 4.
7
Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).新型三重再摄取抑制剂(1S,2S)-3-(甲氨基)-2-(萘-2-基)-1-苯基丙-1-醇(PRC200-SS)的抗抑郁样药理学特征
J Pharmacol Exp Ther. 2008 Nov;327(2):573-83. doi: 10.1124/jpet.108.143610. Epub 2008 Aug 8.
8
Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.血清素5-HT2C受体激动剂:多种疾病的临床前及临床进展
Curr Opin Drug Discov Devel. 2008 Jul;11(4):438-45.
9
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.洛卡塞林,一种新型选择性人5-羟色胺2C激动剂:体外和体内药理学特性
J Pharmacol Exp Ther. 2008 May;325(2):577-87. doi: 10.1124/jpet.107.133348. Epub 2008 Feb 5.
10
Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.(1R)-8-氯-2,3,4,5-四氢-1-甲基-1H-3-苯并氮杂卓(洛卡塞林)的发现及其构效关系,一种用于治疗肥胖症的选择性5-羟色胺5-HT2C受体激动剂
J Med Chem. 2008 Jan 24;51(2):305-13. doi: 10.1021/jm0709034. Epub 2007 Dec 21.